https://www.selleckchem.com/pr....oducts/brm-brg1-atp-
MAIN OUTCOME MEASURES Annual progression rate of myopia and axial length, tolerability to eyedrops, and incidence and severity of unwanted effects. RESULTS Out of 311 children who were referred, 242 were suitable for study participation, and 153 were subsequently enrolled. The baseline characteristics of enrolled participants are presented. CONCLUSIONS AND RELEVANCE Outcomes of the WA-ATOM study will inform on the efficacy, tolerability, safety, and long-term effects of low-dose atropine eyedrops in myopia control in Au
Like
Comment
Share
